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Abstract
Background The aesthetic outcome after burr hole trepanation for the evacuation of chronic subdural hematomas (cSDH) is often
unsatisfactory, as the bony skull defects may cause visible skin depressions. The purpose of this study was to evaluate the efficacy
of burr hole cover placement to improve the aesthetic outcome.
Methods We reviewed consecutive patients treated by burr hole trepanation for cSDH with or without placement of burr hole
covers by a single surgeon between October 2016 and May 2018. The clinical data, including complications, were derived from
the institution’s prospective patient registry. The primary endpoint was the aesthetic outcome, as perceived by patients on the
aesthetic numeric analog (ANA) scale, assessed by means of a standardized telephone interview. Secondary endpoints were skin
depression rates and wound pain, as well as complications.
Results From n = 33, outcome evaluation was possible in n = 28 patients (n = 24 male; mean age of 70.4 ± 16.1 years) with uni-
(n = 20) or bilateral cSDH (n = 8). A total of 14 burr hole covers were placed in 11 patients and compared to 50 burr holes that
were not covered. Patient satisfaction with the aesthetic outcome was significantly better for covered burr holes (mean ANA 9.3
± 0.74 vs. 7.9 ± 1.0; p < 0.001). Skin depressions occurred over 7% (n = 1/14) of covered and over 92% (n = 46/50) of uncovered
burr holes (p < 0.001). There was no difference in wound pain (p = 0.903) between covered and uncovered sites. No surgical site
infection, cSDH recurrence, or material failure was encountered in patients who had received a burr hole plate.
Conclusions In this retrospective series, placement of burr hole covers was associated with improved aesthetic outcome, likely
due to reduction of skin depressions. A randomized controlled trial is developed to investigate whether adding burr hole covers
results in superior aesthetic outcomes, without increasing the risk for complications.
Keywords Burr hole cover . Chronic subdural hematoma . Trepanation . Aesthetic outcome . Complications . Scar . Patient
satisfaction . Burr hole plate
Abbreviations and acronyms
ADL Activities of daily life
ANA Aesthetic numeric analogue scale
cSDH Chronic subdural hematoma
CT Computed tomography
NRS Numeric rating scale
SD Standard deviation
SSI Surgical site infection
Introduction
Chronic subdural hematoma (cSDH) is one of the most com-
mon conditions encountered in the neurosurgical care of el-
derly patients. Due to demographic changes as well as wide-
spread use of antiplatelet and anticoagulant agents, its inci-
dence is further rising [8]. While the roles of adjuvant and
multidisciplinary treatment are under evaluation, surgical
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evacuation remains the backbone in the management of pa-
tients with cSDH [1, 3, 8].
Burr hole trepanation for cSDH is a minimally invasive
procedure, allowing for rapid relief of space-occupying
hematomas and clinical improvement. The likelihood for
recovery of neurological deficits or general functional dis-
ability is high (80–90%) in otherwise healthy patients [2,
9]. Today, there is little doubt that burr hole trepanation is
both safe and effective for this indication.
One downside of burr hole trepanation, however, is
the unsatisfactory aesthetic outcome, as the skin just
above the trepanation site frequently sinks in after he-
matoma reabsorption (Fig. 1). Some patients feel dis-
tinctly troubled by these stigmatizing and often well-
visible skin depressions, and it may even interfere with
activities of daily life (ADLs) [7]. In theory, placing a
burr hole cover after hematoma evacuation may prevent
from this undesirable cosmetic defect. This minor devi-
ation from the regular surgical procedure has been per-
formed by many neurosurgeons over the last decades
but is poorly studied and has not yet found entry into
clinical practice as standard of care.
Methods and materials
The aim of this retrospective study was to evaluate whether
the placement of a burr hole cover after burr hole trepana-
tion for cSDH improves patient satisfaction with the aes-
thetic result. For this, we reviewed the institutional patient
registry [13] to identify consecutive patients who
underwent burr hole trepanation for the evacuation of uni-
or bilateral cSDH by a single surgeon (M.N.S.) between
October 2016 and May 2018. The single-surgeon approach
was chosen, as most other faculty neurosurgeons do not or
only rarely place burr hole covers for this indication.
Clinical and complication data were withdrawn from the
department’s prospective database of complications and out-
come, and disease-specific data were added by reviewing
electronic patient records [9, 13].
Placement of burr hole covers
Depending on the surgeon’s preference, one titanium plate
(Stryker® UN3 BURR HOLE COVER, 20 mm, W/TAB,
item code 53-34520) was placed per burr hole, fixed with
two screws (Stryker® UNIII AXS SCREWS, SELF-
DRILLING, 1.5 × 4MM, item code 56-15934) in some
patients. There were no factors that were strictly and sys-
tematically associated with burr hole cover placement, but
the surgeon was more likely to choose bald patients and
patients in otherwise good functional condition (active
participation in life) to receive a burr hole cover. In gen-
eral, the frontal burr hole was preferably covered while
the parietal burr hole was more often left uncovered, es-
pecially in patients with scalp hair. No burr hole plates
were placed in patients with known systemic infections or
allergic reaction against titanium. Anticoagulation or an-
tiplatelet medication was no exclusion criterion for adding
a burr hole cover. Patients having received a burr hole
cover were informed about the device placement.
Standard management of patients with cSDH
In our department, double burr hole trepanation (14 mm
trepan) is typically performed under general anesthesia
with the patient placed in supine position and rotated head
on a ring-shaped gel cushion [9, 10]. We place the frontal
burr hole at the junction of the superior temporal line and
the coronal suture (stephanion), the posterior burr hole in
the region of the parietal eminence. After trepanation and
dural opening, we evacuate the hematoma by irrigation
with warmed saline solution. We consider drain placement
as standard of care [12] and prefer subperiosteal over sub-
dural drain placement for its better safety profile [2, 15].
When the burr hole cover is placed, it is securely pressed
onto the skull and fixed with two screws. In order to
prevent screws from falling into the subdural space, it is
imperative that the plate covers the burr hole completely
before the screw is received from the scrub nurse.
Postoperatively, patients remain immobilized and flat in
supine position for 48 h until the drain is removed.
Outcome assessment
During a standardized telephone interview (in June 2018)
by a physician not involved in the primary treatment,
Fig. 1 Illustrative picture of a 76-year-old male patient, seen in outpatient
clinics about 12 weeks after right-sided frontal and parietal burr hole
trepanation for a cSDH, with the trepanation site not covered by a burr
hole plate
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patients were asked to separately rate the following items
per burr hole:
– Satisfaction with the aesthetic result of the scar using the
aesthetic numeric analog (ANA) scale, ranging from 0
(unsatisfied) to 10 (very satisfied) [4]
– Subjective impression whether or not the skin is de-
pressed (yes or no)
– Wound pain measured on the numeric rating scale (NRS);
ranging from 0 (no pain) to 100 (extreme pain)
In addition, we recorded the rate of intra- and typical post-
operative complications per patient, including surgical site
infections (SSIs) and recurrent cSDH requiring reoperation,
but also material failure.
Statistical considerations
The null hypothesis was that the satisfaction with the aes-
thetic result of the operation does not differ between burr
holes that are covered (intervention) or not covered by a
burr hole plate (control). The primary endpoint was the
aesthetic outcome on the ANA scale. Secondary end-
points were the rates of skin depression and complica-
tions, as well as wound pain.
For analysis of the primary endpoint, the results ob-
tained in the intervention group were compared to those
of the control group, reported per burr hole. The same
applies to the analysis of skin depression and wound
pain. As the remaining secondary outcomes were not
burr hole-specific but reflected the patient condition as
a whole, the remaining secondary endpoints were re-
ported on a per-patient basis.
For the primary endpoint (quantitative variable on an
interval scale), a rank-sum test was performed to analyze
group differences. The same was applied for analysis of
the NRS-pain outcome, as results were not normally dis-
tributed. The rates of skin depression and complications
were analyzed using Fisher’s exact tests.
Ethical considerations
The local ethics committee (Kantonale Ethikkommission
KEK-ZH 2012–0244) approved the prospective collection
and analysis of data in the patient registry. The study was
registered at http://clinicaltrials.gov (NCT01628406) and
follows the STROBE recommendation for observational
studies. All patients consented to the additional telephone
interview. No funding was received for this study. The
authors report no conflicts of interest.
Results
A total of n = 33 patients were identified, of which n = 5 patients
had to be excluded for study purpose (n = 2 deceased, unrelated
to the surgical intervention; n= 2 patients lost to follow-up de-
spite all efforts; n = 1 patient reached, but unable to speak). None
of these five excluded patients had received a burr hole cover.
The remaining 28 patients (n = 24 male; 85.7%) had a
mean age of 70.4 (± 16.1 years, standard deviation (SD))
and uni- or bilateral cSDH in 20 (71.4%) or 8 cases (28.6%),
respectively (Table 1). A total of 14 burr hole plates (interven-
tion group) were placed in 11 patients (39.3%), 1 single burr
hole plate in n = 8, and 2 burr hole plates in n = 3. A total of 50
burr holes were not covered by plates (control group). A study
algorithm can be found in Fig. 2.
Table 1 Characteristics of included patients, as well as site and number
of applied burr hole covers. CSDH chronic subdural hematoma
No. Sex Age Side of cSDH Burr hole cover
1 Female 76 Both No
2 Male 77 Left No
3 Female 52 Left No
4 Male 92 Both No
5 Male 80 Left No
6 Male 77 Left No
7 Male 83 Left No
8 Male 50 Left No
9 Male 49 Right No
10 Male 52 Left Yes (1; parietal left)
11 Male 64 Right No
12 Male 93 Left No
13 Male 70 Left Yes (1; frontal left)
14 Male 87 Right No
15 Male 76 Right Yes (1; frontal right)
16 Male 35 Right No
17 Male 62 Both Yes (2; frontal and
parietal left)
18 Male 78 Both Yes (1; frontal right)
19 Male 91 Both Yes (1; frontal right)
20 Male 30 Left No
21 Male 69 Left Yes (1; frontal left)
22 Male 72 Both Yes (2; frontal left and
frontal right)
23 Male 74 Right Yes (1; frontal right)
24 Male 73 Both No
25 Male 76 Both Yes (2; frontal and
parietal left)
26 Female 86 Left No
27 Female 62 Right No
28 Male 71 Both Yes (1; frontal left)
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Analysis of the primary endpoint
The mean ANA score in the intervention group was 9.3 (SD
0.74) and 7.9 in the control group (SD 1.0, p < 0.001; Fig. 3).
Analysis of the secondary endpoints
The rate of skin depressions over covered burr holes was 7%
(1/14) in the intervention and 92% (46/50) in the control group
(p < 0.001; Fig. 4), respectively. Mean NRS wound pain was
1.4 (SD 5.3) in the intervention and 2.8 (SD 10.5) in the
control group (p = 0.903).
The cohort was followed for a mean of 270 days (SD 188),
with a longer mean follow-up in patients with a burr hole
cover (346 days, SD 193) versus those without a burr hole
cover (161 days, SD 115; p = 0.019). There was no intraoper-
ative complication associated with burr hole cover placement.
There was no SSI and no material failure in the series. One
patient, who had not received a burr hole cover, was re-
operated 17 days after the primary operation for recurrent
cSDH. No patient who had received a burr hole cover required
a reoperation.
Discussion
This study set out to explore the relationship between place-
ment of a burr hole cover after burr hole trepanation for cSDH
and patient satisfaction with the aesthetic result of the scar. In
this small retrospective series, the patients rated the aesthetic
results of the scar where the underlying burr hole had been
covered by a plate (intervention group) more favorably than
scars over uncovered burr holes. We also found that the rate of
skin depressions was significantly lower over burr holes that
had been covered by a plate and that there was no obvious
increase in undesirable effects, such as wound pain or intra- or
postoperative complications.
The results appear to be valid, as the actual observed out-
comes compare well with the theoretically expected ones,
conferred through the tested variable (placement of burr hole
cover). Based on previous literature and our personal
Fig. 3 Box plot (25th to 75th percentile and mean) with whiskers (5th–
95th percentile) and outliers (points). The mean aesthetic satisfaction
(ANA) score in the intervention group was 9.3 (SD 0.74) and 7.9 in the
control group (SD 1.0, ***p < 0.001)
Fig. 4 The rate of skin depressions over covered burr holes was 7% (1/
14) and 92% (46/50) over burr holes that are not covered (***p < 0.001)
Fig. 2 Study algorithm demonstrating how the intervention and control
groups were arrived at
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experience [7], it could be expected that if a group difference
was observed, this difference would be in favor of the inter-
vention group and measurable on the applied outcome met-
rics. Credibility of our findings is furthermore substantiated by
internal consistency between the outcome measures (aesthetic
satisfaction and rate of skin depression).
Efficacy of burr hole covers to reduce scalp depression
and improve aesthetic outcome
The research question addresses a frequent problem faced in
daily clinical patient care—the undesirable long-term se-
quelae after burr hole trepanation, namely skin depression
and unsatisfactory aesthetic outcome. This is especially the
case in bald patients or those with sparse scalp hair. As
cSDH have a male-to-female ratio of approximately 3:1
[5, 12], the problem of externally visible scalp depressions
potentially applies to a great proportion of all cSDH pa-
tients. But even in patients with full hair, where scalp de-
pressions may not be visible to others, they may interfere
with ADLs, such as hair dressing or combing, in more than
half of the patients [7].
Despite the high prevalence, we were surprised to
learn that there was a scarcity of literature on this topic.
Our results are consistent with the only available previ-
ous report on this topic, originating from South Korea
[7]. In this retrospective cohort study, the authors mea-
sured significantly less (7.4 vs. 91.9%, p < 0.001) and
smaller (0.16 vs. 2.45 mm, p < 0.001) scalp depressions
on the computed tomography (CT) scans obtained in the
follow-up period of patients after burr hole trepanation
with or without placement of titanium burr hole covers.
The authors also performed a telephone interview to ask
patients with scalp depressions about their perceived
impairment: about 74% reported having cosmetic com-
plexes and 62% functional handicaps in the ADLs [7].
Our present findings are in line with the previous re-
port, despite differences in the methodological approach.
In our study, we applied a previously established scale
on aesthetic satisfaction with the surgical site [4] and
we asked patients to judge themselves whether or not
t he sk in ove r t h e bu r r ho l e was dep r e s s ed .
Notwithstanding the methodological differences, both
studies show an impressive reduction of skin depres-
sions from > 90% over uncovered to < 10% over cov-
ered burr holes (Fig. 5). While the prior report did not
assess patient-reported satisfaction—arguably the most
important outcome—our present study indicates that
the subjectively perceived aesthetical result is improved
after placement of a burr hole cover. The improvement
in patient satisfaction is likely conferred through the
decreased prevalence of skin depressions, as wound pain
was similarly low in the study and control group.
Why is the placement of burr hole covers no standard
of care?
In theory, burr hole covers represent an effective, easy-to-ap-
ply, and relatively inexpensive solution to prevent cosmetical-
ly and functionally unfavorable skin depressions. This adjunct
to the regular surgical therapy has not yet found entry into
clinical practice as standard of care, however. A variety of
reasons may be responsible for this, including the lack of
awareness by neurosurgeons, fear of increased intra- and post-
operative complications, or the associated costs.
Awareness of treating physicians may be low due to the
fact that skin depressions are not associated with an imminent
risk to patient health. However, a patient’s perception of the
cosmetic result is an important determinant of satisfaction
with treatment. Owing to the demographic development and
improvements in health care [8, 11], the proportion of elderly
cSDH patients with long-term active participation in life after
burr hole trepanation is increasing. Today’s patients have
evolved into informed customers and service partners, no lon-
ger expecting only the performance of a basic surgical proce-
dure but the delivery of favorable treatment outcomes topped
with an excellent service [14].
Besides allergic reactions (extremely rare against tita-
nium) [6], there is the potential danger of screws falling
into the subdural space, which could prevent neurosur-
geons from applying burr hole covers for this indication.
For the material used in our department, screws do not fit
between the gaps in the permeable burr hole covers.
Therefore, by completely covering the burr hole and firm-
ly pressing it onto the skull before receiving the screws
from the scrub nurse, the risk of screw misplacement can
be minimized.
Fig. 5 Illustrative picture of an 91-year-old male patient, seen in
outpatient clinics about 16 weeks after right-sided frontal and parietal
burr hole trepanation for a cSDH, with the trepanation site covered by a
burr hole plate
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The most important intervention- and disease-specific
complication is cSDH recurrence, necessitating a repeated
surgical intervention in 10–20% of cases [8, 9, 12].
Subsequently, there could be concerns as to whether the place-
ment of burr hole covers interferes with hematoma reabsorp-
tion or drain placement. We preferably place subperiosteal
drains, and the burr hole plates used in our department are
permeable to allow for hematoma clearance from the subdural
into the subperiosteal space. In the present series, no patient
treated with a burr hole cover required a second surgical treat-
ment for hematoma recurrence over a mean follow-up interval
of 5 months. In the study by Im et al., drains were placed into
the subdural space, and burr hole plates with a small gap were
applied to account for the drain (Synthes GmbH, Oberdorf,
Switzerland) [7]. In their series, the authors unfortunately do
not report on hematoma recurrence or need for revision
surgery.
They do, however, report on SSI that was n = 2/196 (1.02%)
in their series, encompassing n = 96 patients with burr hole
covers. Both cases of SSI occurred in patients that had not
received a burr hole cover. Also taking into consideration that
our present analysis did not identify a patient with SSI after
placement of a titanium burr hole cover, the current literature
suggests no obvious increase in infectious complications.
Both the previous group and ours did not experience any
instrument failures such as screw loosening, burr hole cover
displacement, implant protrusion, or scalp perforation [7].
Evidently, the application of osteosynthetic material results
in higher treatment costs, and currently, there is no study that
has addressed the question whether the perceived beneficial
effect (aesthetic and functional) is worth the additional ex-
penses. This is a difficult issue to study, as it is largely influ-
enced by socioeconomic circumstances, and costs for insured
patients emerge for the hospital or the health insurance com-
pany rather than the individual patient. In our practice, the
additional costs for placement of two burr hole plates and four
screws in a patient with unilateral cSDH amount to about SFr
260, Swiss francs (about EUR 225/USD 260). Surveying pa-
tients, neurosurgeons, and health insurance providers may
prove useful in determining the perceived value of this
intervention.
Strengths and limitations
This is the first study to compare subjective patient satis-
faction with the aesthetical result of the scar with or with-
out placement of burr hole covers after trepanation for
cSDH. Despite its small sample size, the study finds a
significant difference on a previously established scale
for aesthetic satisfaction.
Limitations include its retrospective nature, as well as
potential bias by the selection of patients with and without
burr hole covers. As patients were often aware of the fact
whether or not a burr hole cover had been placed, subjects
were not Bblinded^ at the time of the outcome evaluation.
In addition, the study was underpowered to detect signif-
icant group differences for events with a low incidence,
such as SSI or cSDH recurrences.
As for now, this retrospective pilot study reports innovative
and promising findings. Therefore, a sufficiently large prospec-
tive, single-blinded randomized trial is currently developed in
order to investigate whether the addition of a burr hole cover
results in superior aesthetic outcomes, without an increase in
the risks for complications (COveRs to impRove EsthetiC
ouTcome after Surgery for Chronic subdural hemAtoma by
buRr hole trepanation; CORRECT-SCAR trial).
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